3.0
Jun 22, 2021
Current employee
Philadelphia, PA
Recommend
CEO approval
Business Outlook
Pros
Slowly starting to bring its business into 2021 thinking. Enjoyable people. Gumption gets you somewhere.
Cons
Extreme complexity kills speed and nimbleness at GSK : R&D chief does not understand his own business nor cares to - thus needed enterprise, structural, leadership changes are not made: clarity and decisiveness are missing in R&D. Recommend to start over to build anew from the ground up